Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Arch Pharm (Weinheim) ; 357(6): e2400061, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38631672

ABSTRACT

Fragment-based screening has become indispensable in drug discovery. Yet, the weak binding affinities of these small molecules still represent a challenge for the reliable detection of fragment hits. The extent of this issue was illustrated in the literature for the aspartic protease endothiapepsin: When seven biochemical and biophysical in vitro screening methods were applied to screen a library of 361 fragments, very poor overlap was observed between the hit fragments identified by the individual approaches, resulting in high levels of false positive and/or false negative results depending on the mutually compared methods. Here, the reported in vitro findings are juxtaposed with the results from in silico docking and scoring approaches. The docking programs GOLD and Glide were considered with the scoring functions ASP, ChemScore, ChemPLP, GoldScore, DSXCSD, and GlideScore. First, the ranking power and scoring power were assessed for the named scoring functions. Second, the capability of reproducing the crystallized fragment binding modes was tested in a structure-based redocking approach. The redocking success notably depended on the ligand efficiency of the considered fragments. Third, a blinded virtual screening approach was employed to evaluate whether in silico screening can compete with in vitro methods in the enrichment of fragment databases.


Subject(s)
Aspartic Acid Endopeptidases , Molecular Docking Simulation , Aspartic Acid Endopeptidases/antagonists & inhibitors , Aspartic Acid Endopeptidases/metabolism , Aspartic Acid Endopeptidases/chemistry , Ligands , Drug Discovery , Structure-Activity Relationship , Protein Binding , Computer Simulation , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology
2.
EMBO J ; 25(18): 4326-37, 2006 Sep 20.
Article in English | MEDLINE | ID: mdl-16957774

ABSTRACT

hBRCA1 and hBARD1 are tumor suppressor proteins that are involved as heterodimer via ubiquitinylation in many cellular processes, such as DNA repair. Loss of BRCA1 or BARD1 results in early embryonic lethality and chromosomal instability. The Arabidopsis genome carries a BRCA1 homologue, and we were able to identify a BARD1 homologue. AtBRCA1 and the putative AtBARD1 protein are able to interact with each other as indicated by in vitro and in planta experiments. We have identified T-DNA insertion mutants for both genes, which show no visible phenotype under standard growth conditions and are fully fertile. Thus, in contrast to animals, both genes have no indispensable role during development and meiosis in plants. The two single as well as the double mutant are to a similar extent sensitive to mitomycin C, indicating an epistatic interaction in DNA crosslink repair. We could further demonstrate that in Arabidopsis BARD1 plays a prominent role in the regulation of homologous DNA repair in somatic cells.


Subject(s)
Arabidopsis/genetics , DNA Repair/genetics , Genes, Plant , Tumor Suppressor Proteins/genetics , Ubiquitin-Protein Ligases/genetics , Amino Acid Sequence , Arabidopsis/metabolism , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Base Sequence , Breast Neoplasms/genetics , DNA, Bacterial/genetics , DNA, Plant/genetics , DNA, Plant/metabolism , Epistasis, Genetic , Female , Genes, BRCA1 , Humans , Meiosis , Mitomycin/pharmacology , Molecular Sequence Data , Mutagenesis, Insertional , Phenotype , Plants, Genetically Modified , Sequence Homology, Amino Acid
3.
J Neurochem ; 91(4): 1007-17, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15525354

ABSTRACT

G-protein-coupled receptors (GPCRs) are the largest group of cell surface molecules involved in signal transduction and are receptors for a wide variety of stimuli ranging from light, calcium and odourants to biogenic amines and peptides. It is assumed that systematic genomic data-mining has identified the overwhelming majority of all remaining GPCRs in the genome. Here we report the cloning of a novel orphan GPCR which was identified in a search for erythropoietin-induced genes in the brain as a strongly up-regulated gene. This unknown gene coded for a protein which had a seven-transmembrane topology and key features typical of GPCRs of the A family but a low overall identity to all known GPCRs. The protein, coded ee3, has an unusually high evolutionary conservation and is expressed in neurons in diverse areas of the CNS with relation to integrative functions or motor tasks. A yeast two-hybrid screen for interacting proteins revealed binding to the microtubule-associated protein (MAP) 1b. Coupling to MAP1a has been described for another cognate GPCR, the 5-hydroxytryptamine (5HT) 2a receptor. Surprisingly, we found complete colocalization of ee3 and the 5HT2a receptor. The interaction with MAP1b proved to be critical for the stability or folding of ee3 as in mice lacking MAP1b the ee3 protein was undetectable by immunohistochemistry, although messenger RNA levels remained unchanged. We propose that ee3 is a highly interesting new orphan GPCR with potential connections to erythropoietin and 5HT2a receptor signalling.


Subject(s)
Erythropoietin/pharmacology , Microtubule-Associated Proteins/metabolism , Nerve Tissue Proteins/genetics , Neurons/metabolism , Receptor, Serotonin, 5-HT2A/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Amino Acid Sequence , Animals , Brain/drug effects , Brain/metabolism , Cloning, Molecular , Humans , Mice , Mice, Transgenic , Microtubule-Associated Proteins/genetics , Molecular Sequence Data , Multigene Family , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Organ Specificity , Rats , Sequence Homology, Amino Acid , Two-Hybrid System Techniques , Up-Regulation/drug effects , Up-Regulation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...